Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Neuronetics, Inc. roe for the quarter ending 2026-06-30 was -170.49%, a change of 9.27% year-over-year.
Neuronetics, Inc. roe for the quarter ending 2026-03-31 was -279.78%, a change of -142.95% year-over-year.
Neuronetics, Inc. roe for the quarter ending 2025-12-31 was -174.27%, a change of -16.51% year-over-year.
Neuronetics, Inc. roe for the quarter ending 2025-09-30 was -162.68%, a change of 225.59% year-over-year.
Neuronetics, Inc. roe for fiscal 2025 was -174.27%, a change of -16.51% from fiscal 2024.
Neuronetics, Inc. roe for fiscal 2024 was -157.76%, a change of -69.46% from fiscal 2023.
Neuronetics, Inc. roe for fiscal 2023 was -88.30%, a change of -23.18% from fiscal 2022.
Neuronetics, Inc. roe for fiscal 2022 was -65.12%, a change of -28.50% from fiscal 2021.